LeMaitre Vascular director awarded dividend rights

LEMAITRE VASCULAR INC (symbol: LMAT) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC (symbol: LMAT) is the issuer of record for a Form 4 filing submitted to the SEC. Roush John A reported acquisition or exercise transactions in this Form 4 filing.

LEMAITRE VASCULAR INC (LMAT) reported that director John A. Roush received multiple small grants of dividend equivalent rights on September 3, 2026. These rights accrued on previously granted restricted stock unit and performance share unit awards from December 2023, December 2024, and December 2025.

Each dividend equivalent right is disclosed as the economic equivalent of one share of common stock and will vest proportionately with the underlying stock unit or performance share awards. No cash price was paid for these derivative awards, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 4.7443 shares

Grant/Award 5 txns

Insider Roush John A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	0.5429	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F2	0.6503	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F3	0.8852	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F4	1.0022	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F5	1.6637	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 26.0982 contracts (Direct)

Footnotes (5)

1. F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend equivalent rights grant 1: 0.5429 rights Dividend equivalent rights grant 2: 0.6503 rights Dividend equivalent rights grant 3: 0.8852 rights +2 more

5 metrics

Dividend equivalent rights grant 1 0.5429 rights Accrued on a restricted stock unit award granted on December 8, 2023

Dividend equivalent rights grant 2 0.6503 rights Accrued on a performance share unit award granted on December 8, 2023

Dividend equivalent rights grant 3 0.8852 rights Accrued on a restricted stock unit award granted on December 6, 2024

Dividend equivalent rights grant 4 1.0022 rights Accrued on a performance share unit award granted on December 6, 2024

Dividend equivalent rights grant 5 1.6637 rights Accrued on a restricted stock unit award granted on December 10, 2025

Key Terms

Dividend equivalent rights, restricted stock unit award, performance share unit award, economic equivalent

4 terms

Dividend equivalent rights financial

"These dividend equivalent rights accrued on a restricted stock unit award"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit award financial

"These dividend equivalent rights accrued on a restricted stock unit award"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

performance share unit award financial

"These dividend equivalent rights accrued on a performance share unit award"

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LMAT disclose for John A. Roush on September 3, 2026?

LMAT disclosed that director John A. Roush acquired several small grants of dividend equivalent rights on September 3, 2026. These derivative awards relate to earlier restricted stock unit and performance share unit grants and carry no stated purchase price.

How many dividend equivalent rights were granted to the LMAT director in this Form 4?

The Form 4 reports five separate grants of dividend equivalent rights to the LMAT director, in amounts of 0.5429, 0.6503, 0.8852, 1.0022, and 1.6637 rights, each tied to a specific prior stock unit or performance share award.

What are dividend equivalent rights in the context of LMAT’s Form 4 filing?

The filing states that each dividend equivalent right is the economic equivalent of one share of LMAT common stock. These rights accrued on existing restricted stock unit and performance share unit awards and will vest proportionately with those underlying awards.

Which LMAT equity awards generated the new dividend equivalent rights?

The dividend equivalent rights accrued on LMAT awards granted on December 8, 2023, December 6, 2024, and December 10, 2025. They are linked to both restricted stock unit awards and performance share unit awards granted on those dates.

Were the LMAT dividend equivalent rights granted under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not selected, so the reported grants of dividend equivalent rights to the LMAT director are not affirmed as being made under a Rule 10b5-1 trading plan.

Do the LMAT dividend equivalent rights have a purchase price?

The Form 4 reports a transaction price of $0.0000 per right for each of the dividend equivalent right grants, indicating they were awarded without a cash purchase price as part of the director’s equity-based compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:45 PM Accepted by SEC EDGAR 09/08/2026 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roush John A

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, 63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/03/2026		A		0.5429		(1)	(1)	Common Stock	0.5429	$0	5.6103	D
Dividend Equivalent Rights	(2)	09/03/2026		A		0.6503		(2)	(2)	Common Stock	0.6503	$0	5.5195	D
Dividend Equivalent Rights	(3)	09/03/2026		A		0.8852		(3)	(3)	Common Stock	0.8852	$0	5.1836	D
Dividend Equivalent Rights	(4)	09/03/2026		A		1.0022		(4)	(4)	Common Stock	1.0022	$0	5.486	D
Dividend Equivalent Rights	(5)	09/03/2026		A		1.6637		(5)	(5)	Common Stock	1.6637	$0	4.2988	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Douglas G. Bush, Attorney-in-fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)